Guardant Health (GH) Issues Quarterly Earnings Results, Misses Expectations By $1.65 EPS
Guardant Health (NASDAQ:GH) released its earnings results on Monday. The company reported ($1.94) EPS for the quarter, missing the consensus estimate of ($0.29) by ($1.65), Briefing.com reports. The company had revenue of $21.70 million during the quarter, compared to analyst estimates of $17.44 million. The firm’s revenue was up 95.5% on a year-over-year basis. Guardant Health updated its FY 2018 guidance to EPS.
GH stock opened at $33.62 on Tuesday. Guardant Health has a twelve month low of $27.04 and a twelve month high of $44.25.
A number of equities research analysts have commented on GH shares. Leerink Swann reissued an “outperform” rating on shares of Guardant Health in a research note on Monday, October 29th. William Blair started coverage on Guardant Health in a research note on Monday, October 29th. They issued an “outperform” rating for the company. Cowen started coverage on Guardant Health in a research note on Monday, October 29th. They issued an “outperform” rating for the company. Bank of America started coverage on Guardant Health in a research note on Monday, October 29th. They issued a “neutral” rating and a $37.00 price objective for the company. Finally, JPMorgan Chase & Co. started coverage on Guardant Health in a research note on Monday, October 29th. They issued an “overweight” rating and a $42.00 price objective for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Guardant Health currently has an average rating of “Buy” and a consensus target price of $39.50.
Guardant Health Company Profile
Guardant Health, Inc, a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA.
Featured Story: Dow Jones Industrial Average (DJIA)
Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.